{
  "cui": "C3553720",
  "cui_name": "CFHR5 DEFICIENCY",
  "incidence_per_100k": null,
  "prevalence_per_100k": 0.1,
  "metric_type": "prevalence",
  "total_cases_per_year": 8000,
  "confidence": 0.3,
  "is_subtype": true,
  "parent_disease": "C3 Glomerulopathy",
  "reasoning": "Rare form of C3 glomerulonephritis/C3 glomerulopathy with CFHR5 mutations. Endemic in Cyprus with founder effect mutation (exon 2-3 duplication affecting 91 patients from 16 families). Cases also reported in Turkish descent populations. Global prevalence estimated at approximately 0.1 per 100k based on limited case reports and family studies.",
  "data_quality": "weak",
  "geographic_variation": "high",
  "year_specific": false,
  "data_year": null,
  "source": "GeneReviews (NCBI Bookshelf), Frontiers in Immunology 2022 - CFH and CFHR structural variants in aHUS",
  "source_url": "https://www.ncbi.nlm.nih.gov/books/NBK1367/",
  "source_type": "literature"
}
